{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:52Z","timestamp":1786118812823,"version":"build-2736575974"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Cisplatin is an effective anticancer drug that can induce cochleotoxicity in up to 50 to 60% of treated patients. However, the vestibulotoxic potential of cisplatin remains unclear. Our lab previously developed a multicycle model of cisplatin administration in mice that results in hearing loss similar to that observed clinically. The purpose of this study was to comprehensively characterize the functional and morphological consequences of cisplatin on the vestibular periphery in this mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Twenty-nine adult CBA\/CaJ mice were assigned to control or cisplatin-treated groups. Cisplatin-treated mice received three consecutive cycles of once-daily cisplatin for 4 days followed by a 10-day recovery period. Mice underwent vestibular sensory evoked potential testing before cisplatin administration, after the final cycle of cisplatin, and 6 mo after treatment cessation. Mice also underwent vestibulo-ocular reflex testing and vestibular afferent single-unit recordings 6 mo after treatment cessation. Following testing, utricles, saccules, and horizontal semicircular canals were microdissected, and vestibular morphology was examined. To examine whether our data in mice were consistent with reports of cisplatin-induced vestibulotoxicity in patients, histopathology reports of human temporal bones were examined for evidence of cisplatin-induced vestibulotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Vestibular sensory evoked potential thresholds were significantly elevated in cisplatin-treated mice immediately after cessation of cisplatin administration and progressively worsened 6 mo later. Rotational and translational vestibulo-ocular reflexes were generally unaffected by cisplatin. Cisplatin did not cause statistically significant changes in the spontaneous firing rates of semicircular canal afferents but did cause significant decreases in their overall regularity. No statistically significant differences in the spontaneous firing rates or regularity of otolith afferents were observed. However, cisplatin-treated mice exhibited statistically significant decreases in the percentage of low-distortion otolith afferents, indicating that responses of these afferents to head translations were more variable and less precise. Cisplatin-treated mice showed significantly decreased hair cell numbers in the saccule but not in the utricle or horizontal semicircular canal. One temporal bone histopathology report from an individual treated with high cumulative cisplatin was consistent with the results of our study, showing only saccular degeneration with normal utricle and semicircular canal morphology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study demonstrates cisplatin\u2019s potential to affect the vestibular end organs adversely and differentially. The saccule was uniquely susceptible in our mouse model, suggesting that it may be possible to screen for cisplatin-induced vestibulotoxicity by testing saccular function. While very little is known about the potential for progression of cisplatin-induced vestibulotoxicity, our results suggest vestibular dysfunction may continue to worsen after cessation of cisplatin treatment. We recommend that ongoing and future efforts at evaluating vestibular function in patients treated with cisplatin include monitoring and evaluation of otolith function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aud.0000000000001772","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T05:00:12Z","timestamp":1767157212000},"page":"777-789","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cisplatin Differentially Damages Mammalian Vestibular End Organs"],"prefix":"10.1097","volume":"47","author":[{"given":"John","family":"Lee","sequence":"first","affiliation":[{"name":"National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head and Neck Surgery, Balance and Auditory Research Center (BARC), University of Mississippi Medical Center, Jackson, Mississippi, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head and Neck Surgery, Balance and Auditory Research Center (BARC), University of Mississippi Medical Center, Jackson, Mississippi, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"R1-20260414","article-title":"Risk of dying from cancer continues to drop at an accelerated pace.","year":"2022","journal-title":"American Cancer Society"},{"key":"R2-20260414","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1152\/jn.1993.69.3.996","article-title":"Contribution of irregular semicircular canal afferents to the horizontal vestibuloocular response during constant velocity rotation.","volume":"69","author":"Angelaki","year":"1993","journal-title":"J Neurophysiol"},{"key":"R3-20260414","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10162-014-0491-7","article-title":"Heat shock protein-mediated protection against cisplatin-induced hair cell death.","volume":"16","author":"Baker","year":"2015","journal-title":"J Assoc Res Otolaryngol"},{"key":"R4-20260414","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss.","volume":"26","author":"Bertolini","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-20260414","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1288\/00005537-198212000-00003","article-title":"Cisplatin vestibular ototoxicity: Preliminary report.","volume":"92","author":"Black","year":"1982","journal-title":"Laryngoscope"},{"key":"R6-20260414","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R7-20260414","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy.","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat Commun"},{"issue":"sup4","key":"R8-20260414","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1080\/14992027.2017.1355570","article-title":"Ototoxicity monitoring in children treated with platinum chemotherapy.","volume":"57","author":"Brooks","year":"2018","journal-title":"Int J Audiol"},{"key":"R9-20260414","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcdb.2016.11.001","article-title":"Development and regeneration of vestibular hair cells in mammals.","volume":"65","author":"Burns","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"R10-20260414","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2017.02.007","article-title":"Dose-dependent cochlear and vestibular toxicity of trans-tympanic cisplatin in the rat.","volume":"60","author":"Callejo","year":"2017","journal-title":"Neurotoxicology"},{"key":"R11-20260414","doi-asserted-by":"crossref","first-page":"e26992","DOI":"10.1002\/pbc.26992","article-title":"Determining the prevalence of vestibular screening failures in pediatric cancer patients whose therapies include radiation to the head\/neck and platin-based therapies: A pilot study.","volume":"65","author":"Camet","year":"2018","journal-title":"Pediatric Blood Cancer"},{"key":"R12-20260414","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0022215108002624","article-title":"Stria vascularis and vestibular dark cells: Characterisation of main structures responsible for inner-ear homeostasis, and their pathophysiological relations.","volume":"123","author":"Ciuman","year":"2009","journal-title":"J Laryngol Otol"},{"key":"R13-20260414","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPH.0b013e318059c220","article-title":"Ototoxicity from cisplatin therapy in childhood cancer.","volume":"29","author":"Coradini","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"R14-20260414","doi-asserted-by":"crossref","first-page":"107878","DOI":"10.1016\/j.heares.2019.107878","article-title":"Cisplatin-induced threshold shift in the CBA\/CaJ, C57BL\/6J, BALB\/cJ mouse models of hearing loss.","volume":"387","author":"DeBacker","year":"2020","journal-title":"Hear Res"},{"key":"R15-20260414","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.joto.2018.08.002","article-title":"Cisplatin-induced vestibular hair cell lesion-less damage at high doses.","volume":"13","author":"Ding","year":"2018","journal-title":"J Otol"},{"key":"R16-20260414","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13064-019-0126-0","article-title":"Degeneration of saccular hair cells caused by MITF gene mutation.","volume":"14","author":"Du","year":"2019","journal-title":"Neural Dev"},{"key":"R17-20260414","doi-asserted-by":"crossref","first-page":"e2410063","DOI":"10.1002\/advs.202410063","article-title":"Long-lasting auditory and vestibular recovery following gene replacement therapy in a novel Usher syndrome type 1c mouse model.","volume":"12","author":"Du","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"R18-20260414","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-neuro-061010-113710","article-title":"Vestibular hair cells and afferents: Two channels for head motion signals.","volume":"34","author":"Eatock","year":"2011","journal-title":"Annu Rev Neurosci"},{"key":"R19-20260414","doi-asserted-by":"crossref","first-page":"NP337","DOI":"10.1177\/01455613221115042","article-title":"Changes in vestibular and cochlear function following platinum-based chemotherapy: A preliminary report.","volume":"104","author":"Ehlert","year":"2025","journal-title":"Ear Nose Throat J"},{"key":"R20-20260414","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","article-title":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.","volume":"375","author":"Fernandez","year":"2019","journal-title":"Hear Res"},{"key":"R21-20260414","doi-asserted-by":"crossref","first-page":"e142616","DOI":"10.1172\/JCI142616","article-title":"Atorvastatin is associated with reduced cisplatin-induced hearing loss.","volume":"131","author":"Fernandez","year":"2021","journal-title":"J Clin Invest"},{"key":"R22-20260414","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer.","volume":"34","author":"Frisina","year":"2016","journal-title":"J Clin Oncol"},{"key":"R23-20260414","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7874\/jao.2017.00360","article-title":"Ototoxicity: A challenge in diagnosis and treatment.","volume":"22","author":"Ganesan","year":"2018","journal-title":"J Audiol Otol"},{"issue":"3S","key":"R24-20260414","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1044\/2021_AJA-21-00031","article-title":"Clinical considerations for routine auditory and vestibular monitoring in patients with cystic fibrosis.","volume":"30","author":"Garinis","year":"2021","journal-title":"Am J Audiol"},{"key":"R25-20260414","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002210050033","article-title":"Afferent diversity and the organization of central vestibular pathways.","volume":"130","author":"Goldberg","year":"2000","journal-title":"Exp Brain Res"},{"key":"R26-20260414","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/CAD.0000000000000395","article-title":"Ototoxicity of 12\u2009mg\/kg cisplatin in the Fischer 344\/NHsd rat using multiple dosing strategies.","volume":"27","author":"Harrison","year":"2016","journal-title":"Anticancer Drugs"},{"key":"R27-20260414","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000275652","article-title":"cis-Diamminedichloroplatinum: A cytostatic with an ototoxic effect.","volume":"45","author":"Hartwig","year":"1983","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R28-20260414","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/lio2.608","article-title":"Cisplatin ototoxicity histopathology.","volume":"6","author":"Hodge","year":"2021","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"R29-20260414","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10162-022-00839-1","article-title":"Differential activation of canal and otolith afferents by acoustic tone bursts in rats.","volume":"23","author":"Huang","year":"2022","journal-title":"J Assoc Res Otolaryngol"},{"key":"R30-20260414","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0145561320949482","article-title":"Changes in vestibular function in patients with head-and-neck cancer undergoing chemoradiation.","volume":"101","author":"H\u00fclse","year":"2022","journal-title":"Ear Nose Throat J"},{"key":"R31-20260414","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.heares.2004.01.008","article-title":"Gravity receptor function in mice with graded otoconial deficiencies.","volume":"191","author":"Jones","year":"2004","journal-title":"Hear Res"},{"key":"R32-20260414","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5955(99)00110-0","article-title":"Short latency compound action potentials from mammalian gravity receptor organs.","volume":"136","author":"Jones","year":"1999","journal-title":"Hear Res"},{"key":"R33-20260414","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10162-014-0501-9","article-title":"On the high frequency transfer of mechanical stimuli from the surface of the head to the macular neuroepithelium of the mouse.","volume":"16","author":"Jones","year":"2015","journal-title":"J Assoc Res Otolaryngol"},{"key":"R34-20260414","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hed.20892","article-title":"Role of proinflammatory cytokines in cisplatin-induced vestibular hair cell damage.","volume":"30","author":"Kim","year":"2008","journal-title":"Head Neck"},{"key":"R35-20260414","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/000348946907800311","article-title":"Distribution, structure, and function of dark cells in the vestibular labyrinth.","volume":"78","author":"Kimura","year":"1969","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R36-20260414","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/019459988809800114","article-title":"Active head-movement analysis of cisplatin-induced vestibulotoxicity.","volume":"98","author":"Kitsigianis","year":"1988","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R37-20260414","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2016.69.2319","article-title":"Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): A report from the Children\u2019s Oncology Group.","volume":"35","author":"Knight","year":"2017","journal-title":"J Clin Oncol"},{"key":"R38-20260414","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000275909","article-title":"Clinical features of cisplatin vestibulotoxicity and hearing loss.","volume":"49","author":"Kobayashi","year":"1987","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R39-20260414","doi-asserted-by":"crossref","first-page":"e181201","DOI":"10.1172\/JCI181201","article-title":"Pharmacological regeneration of sensory hair cells restores afferent innervation and vestibular function.","volume":"134","author":"Lahlou","year":"2024","journal-title":"J Clin Invest"},{"key":"R40-20260414","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: Mechanisms, pharmacogenetics, and protective strategies.","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"R41-20260414","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.ymthe.2020.08.002","article-title":"Direct delivery of antisense oligonucleotides to the middle and inner ear improves hearing and balance in usher mice.","volume":"28","author":"Lentz","year":"2020","journal-title":"Mol Ther"},{"key":"R42-20260414","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ntt.2015.07.004","article-title":"Assessment of D-methionine protecting cisplatin-induced otolith toxicity by vestibular-evoked myogenic potential tests, ATPase activities and oxidative state in guinea pigs.","volume":"51","author":"Lo","year":"2015","journal-title":"Neurotoxicol Teratol"},{"key":"R43-20260414","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.otohns.2005.04.024","article-title":"Efficacy of vestibular rehabilitation therapy in reducing falls.","volume":"133","author":"Macias","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R44-20260414","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1523\/JNEUROSCI.11-06-01636.1991","article-title":"Vestibular-nerve inputs to the vestibulo-ocular reflex: A functional-ablation study in the squirrel monkey.","volume":"11","author":"Minor","year":"1991","journal-title":"J Neurosci"},{"key":"R45-20260414","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S2352-4642(21)00020-1","article-title":"Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: A multi-institutional North American cohort study.","volume":"5","author":"Moke","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R46-20260414","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clon.2020.03.011","article-title":"Falls and cancer.","volume":"32","author":"Morris","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R47-20260414","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/019459989310800403","article-title":"Is cis-platinum vestibulotoxic?","volume":"108","author":"Myers","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R48-20260414","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human.","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"R49-20260414","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00005537-199602000-00011","article-title":"Quantitative study of vestibulotoxicity induced by gentamicin or cisplatin in the guinea pig.","volume":"106","author":"Nakayama","year":"1996","journal-title":"The Laryngoscope"},{"key":"R50-20260414","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41467-018-08264-w","article-title":"Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders.","volume":"10","author":"Nist-Lund","year":"2019","journal-title":"Nat Commun"},{"key":"R51-20260414","doi-asserted-by":"crossref","first-page":"dev192070","DOI":"10.1242\/dev.192070","article-title":"Retinoic acid synthesis and autoregulation mediate zonal patterning of vestibular organs and inner ear morphogenesis.","volume":"147","author":"Ono","year":"2020","journal-title":"Development"},{"key":"R52-20260414","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MOO.0b013e32834aba84","article-title":"Cost-effective evaluation of the vestibular patient.","volume":"19","author":"Phillips","year":"2011","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R53-20260414","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1097\/MAO.0000000000003079","article-title":"Imbalance associated with cisplatin chemotherapy in adult cancer survivors: A clinical study.","volume":"42","author":"Prayuenyong","year":"2021","journal-title":"Otol Neurotol"},{"key":"R54-20260414","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fonc.2018.00363","article-title":"Vestibulotoxicity associated with platinum-based chemotherapy in survivors of cancer: A scoping review.","volume":"8","author":"Prayuenyong","year":"2018","journal-title":"Front Oncol"},{"key":"R55-20260414","doi-asserted-by":"crossref","first-page":"1356614","DOI":"10.3389\/fneur.2024.1356614","article-title":"TMC function, dysfunction, and restoration in mouse vestibular organs.","volume":"15","author":"Ratzan","year":"2024","journal-title":"Front Neurol"},{"key":"R56-20260414","article-title":"Cancer.","author":"Roser","year":"2015","journal-title":"Our World in Data"},{"key":"R57-20260414","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0039-1684048","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention.","volume":"40","author":"Rybak","year":"2019","journal-title":"Semin Hear"},{"key":"R58-20260414","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/1097-0142(19810301)47:5<857::AID-CNCR2820470508>3.0.CO;2-M","article-title":"Cis-platinum vestibular toxicity.","volume":"47","author":"Schaefer","year":"1981","journal-title":"Cancer"},{"key":"R59-20260414","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1523\/JNEUROSCI.5842-08.2009","article-title":"Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.","volume":"29","author":"Schmitt","year":"2009","journal-title":"J Neurosci"},{"key":"R60-20260414","doi-asserted-by":"crossref","first-page":"1376128","DOI":"10.3389\/fnmol.2024.1376128","article-title":"Recovery kinetics of dual AAV-mediated human otoferlin expression.","volume":"17","author":"Sellon","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"R61-20260414","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(03)00142-4","article-title":"Cisplatin ototoxicity in the guinea pig: Vestibular and cochlear damage.","volume":"182","author":"Sergi","year":"2003","journal-title":"Hear Res"},{"key":"R62-20260414","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archotol.1966.00760030397003","article-title":"Biochemical studies of inner ear fluid in man. Changes in otosclerosis, Meniere\u2019s disease, and acoustic neuroma.","volume":"84","author":"Silverstein","year":"1966","journal-title":"Arch Otolaryngol"},{"key":"R63-20260414","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/dvdy.24150","article-title":"Cisplatin exposure damages resident stem cells of the mammalian inner ear.","volume":"243","author":"Slattery","year":"2014","journal-title":"Dev Dyn"},{"key":"R64-20260414","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5955(87)90022-0","article-title":"Strial dysfunction in mice with cochleo-saccular abnormalities.","volume":"27","author":"Steel","year":"1987","journal-title":"Hear Res"},{"key":"R65-20260414","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.heares.2016.03.002","article-title":"Effects of high intensity noise on the vestibular system in rats.","volume":"335","author":"Stewart","year":"2016","journal-title":"Hear Res"},{"key":"R66-20260414","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fncel.2017.00331","article-title":"Partial aminoglycoside lesions in vestibular epithelia reveal broad sensory dysfunction associated with modest hair cell loss and afferent calyx retraction.","volume":"11","author":"Sultemeier","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"R68-20260414","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5152\/iao.2022.21207","article-title":"Measure of central vestibular compensation: A review.","volume":"18","author":"Swamy Suman","year":"2022","journal-title":"J Int Adv Otol"},{"key":"R69-20260414","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.toxlet.2016.09.009","article-title":"Cisplatin-induced toxicity decreases the mouse vestibulo-ocular reflex.","volume":"262","author":"Takimoto","year":"2016","journal-title":"Toxicol Lett"},{"key":"R70-20260414","doi-asserted-by":"crossref","first-page":"16545","DOI":"10.3390\/ijms242216545","article-title":"Molecular characteristics of cisplatin-induced ototoxicity and therapeutic interventions.","volume":"24","author":"Tan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R71-20260414","doi-asserted-by":"crossref","first-page":"718241","DOI":"10.3389\/fnmol.2021.718241","article-title":"Single-Cell RNA-Seq of cisplatin-treated adult stria vascularis identifies cell type-specific regulatory networks and novel therapeutic gene targets.","volume":"14","author":"Taukulis","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"R72-20260414","first-page":"319","article-title":"Body condition scoring: A rapid and accurate method for assessing health status in mice.","volume":"49","author":"Ullman-Culler\u00e9","year":"1999","journal-title":"Lab Anim Sci"},{"key":"R73-20260414","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0277-5379(83)90398-X","article-title":"Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration.","volume":"19","author":"Vermorken","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R74-20260414","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijporl.2018.01.028","article-title":"Long term platinum-induced ototoxicity in pediatric patients.","volume":"107","author":"Waissbluth","year":"2018","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R75-20260414","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00003446-199104000-00003","article-title":"Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: Influence of dosage and schedule of administration.","volume":"12","author":"Waters","year":"1991","journal-title":"Ear Hear"},{"key":"R76-20260414","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1288\/00005537-198212000-00013","article-title":"Inner ear histopathology in patients treated with cis-platinum.","volume":"92","author":"Wright","year":"1982","journal-title":"Laryngoscope"},{"key":"R77-20260414","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.apjon.2022.100107","article-title":"Risk factors for falls in hospitalized patients with cancer: A systematic review and meta-analysis.","volume":"9","author":"Zhao","year":"2022","journal-title":"Asia Pac J Oncol Nurs"},{"key":"R78-20260414","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1152\/jn.00003.2011","article-title":"Click-evoked responses in vestibular afferents in rats.","volume":"106","author":"Zhu","year":"2011","journal-title":"J Neurophysiol"}],"container-title":["Ear &amp; Hearing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AUD.0000000000001772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:46:40Z","timestamp":1786034800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AUD.0000000000001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aud.0000000000001772","relation":{},"ISSN":["1538-4667"],"issn-type":[{"value":"1538-4667","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}